Cargando…
GLP-1 Induces the Expression of FNDC5 Derivatives That Execute Lipolytic Actions
Multiple GLP-1-derived therapeutics are clinically used to treat type 2 diabetes and obesity. However, the underlying mechanism of how these drugs regulate the body weight of obese patients remains incompletely understood. Here, we report that the lipolysis effects of GLP-1 on β cells can depend on...
Autores principales: | Li, Hui, Donelan, William, Wang, Fang, Zhang, Peilan, Yang, Lijun, Ding, Yousong, Tang, Dongqi, Li, Shiwu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636013/ https://www.ncbi.nlm.nih.gov/pubmed/34869379 http://dx.doi.org/10.3389/fcell.2021.777026 |
Ejemplares similares
-
Expression of Recombinant Rat Secretable FNDC5 in Pichia Pastoris and Detection of Its Biological Activity
por: Zhao, Yi, et al.
Publicado: (2022) -
Mimicking lipolytic, adipogenic, and secretory capacities of human subcutaneous adipose tissue by spheroids from distinct subpopulations of adipose stromal/stem cells
por: Côrtes, Isis, et al.
Publicado: (2023) -
Circular RNA circFNDC3AL Upregulates BCL9 Expression to Promote Chicken Skeletal Muscle Satellite Cells Proliferation and Differentiation by Binding to miR-204
por: Wei, Yuanhang, et al.
Publicado: (2021) -
Distinct Identity of GLP-1R, GLP-2R, and GIPR Expressing Cells and Signaling Circuits Within the Gastrointestinal Tract
por: Morrow, Nadya M., et al.
Publicado: (2021) -
Characterization and mechanism of action of amphibian-derived wound-healing-promoting peptides
por: Wang, Xiakun, et al.
Publicado: (2023)